Coulter Corporation
San Francisco
About Coulter Corporation
Coulter Pharmaceutical is engaged in the development of novel drugs and therapies for the treatment of people with cancer. The Company currently is developing a family of cancer therapeutics based upon two platform technologies: conjugated antibodies and tumor-activated peptide pro-drugs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Ticker: nasdaq:CLTR
Canonical: https://fsome.com/organization/coulter-corporation-2305401 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.